Recombinant Human Myostatin Propeptide Reference: P4084 Synonyms: Cmpt, GDF-8, GDF8_HUMAN, Growth/differentiation factor 8, MSLHP, MSTN, MSTN myostatin, Myostatin, Myostatin Propeptide. Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4
Recombinant Human Natriuretic Peptide Receptor A Reference: P4799 Synonyms: ANP-A, ANPa, ANPR-A, ANPRA, ANPRA_HUMAN, Atrial natriuretic peptide A type receptor, Atrial natriuretic peptide receptor 1, Atrial natriuretic peptide receptor A, Atrial natriuretic peptide receptor type A, Atrionatriuretic peptide receptor A, GC A, GC-A, Guanylate cyclase, Guanylate cyclase A, GUC2A, GUCY2A, Natriuretic peptide A type receptor, Natriuretic Peptide Receptor A. Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4
TrkB control peptide (54-67), Purified Peptide-100 µg Reference: PE-1252-100 This peptide may be used to block binding activity of antibody to TrkB (# R-121-100).
Parkin control peptide (305-323), Purified Peptide-100 µg Reference: PE-1253-100 This peptide may be used to block binding activity of antibody to Parkin (# R-113-100).
Alpha synuclein control peptide (116-131), Purified Peptide-100 µg Reference: PE-1606-100 Alpha synuclein control peptide (116-131), Purified Peptide, suitable to Block.
Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg Reference: PE-1749-50 Synthetic beta-amyloid Aβ1-42 was monomerized by HFIP (hexafluoro-2-propanol) treatment and dried. One vial contains 50 μg monomeric Aβ peptide that can be used to form solutions of unaggregated Aβ monomers, aggregated Aβ oligomers, Aβ fibrils and Aβ protein complexes according to published protocols, and used in a variety of research applications.
Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng Reference: PE-1750-1000 A proprietary preparation of human amyloid beta peptide (amino acids 1-42) that was initially monomerized by HFIP-treatment and then allowed to form oligomers by the procedure described in Youmans KL et al., 2012, followed by lyophilisation using Biosensis' proprietary stabilization procedures.The resulting oligomeric mixture has been specially designed to allow the formation of stable, oligomeric Aβ1-42 peptide, multimeric complexes or oligomers. The material is intended to be used as a stable and consistent standard or positive control for oligomeric ELISA assays, as well as other research applications.
Choline O-acetyltransferase (ChAT) control peptide (167-188), Purified... Reference: PE-1762-100 This peptide may be used to block binding activity of antibody to ChAT (# R-043-100 and # R-1621-100).
Z-VEID-FMK Reference: HY-P1007 Z-VEID-FMK is a selective inhibitor of caspase-6. Z-VEID-FMK can be used for the research of tumor.
Hexa-His TFA Reference: HY-P0294A Hexa-His TFA is a peptide consisting of 6 His residues, used as a metal binding site for the recombinant protein.